Insulet Corporation (PODD)
NASDAQ · Healthcare
Insulet Corporation EBITDA 2009–2025
Insulet Corporation annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Insulet Corporation ebitda for the quarter ending March 31, 2026 was 148.3 M, a 34.21% increase year-over-year.
- Insulet Corporation ebitda for the twelve months ending March 31, 2026 was 379.4 M, a 241.49% increase year-over-year.
- Insulet Corporation annual ebitda for 2025 was 564.2 M, a 44.78% increase from 2024.
- Insulet Corporation annual ebitda for 2024 was 389.7 M, a 33.05% increase from 2023.
- Insulet Corporation annual ebitda for 2023 was 292.9 M, a 190.58% increase from 2022.
- Insulet Corporation annual ebitda for 2022 was 100.8 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Insulet Corporation EBITDA — FAQ
Insulet Corporation (PODD) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PODD's ebitda history?
The chart and table above show Insulet Corporation's ebitda by year and by quarter, including the growth rate.